2013 glutathione parkinson's disease four authors

2013 glutathione parkinson's disease four authors PDF) Deficiency in Disease: Intranasal Administration as a Method of Augmentation Evidence for Glutathione Deficiency Targeting the Cysteine Redox Proteome

Name: 2013 glutathione parkinson's disease four authors PDF) Deficiency in Disease: Intranasal Administration as a Method of Augmentation Evidence for Glutathione Deficiency Targeting the Cysteine Redox Proteome
Brand: cantondelareina.com.ar
SKU: 89791875395
Price: 27.64 USD
Availability: InStock
Rating: 4.1872 (16 reviews)

Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Glutathione Precursors and Beyond Parkinson's disease The Lancet Potential use of glutathione as a treatment for Parkinson's disease PMC Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson's model Cell Death & Disease

SKU: 89791875395 · From cantondelareina.com.ar

4.2

USD27.64 USD70.64

Pay in 4 interest-free payments of $6.91 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 11 - Aug 16

Description

In addition, mitochondrial lipid peroxidation derivatives can damage membranes by altering their barrier function by either directly interacting with membrane proteins and/or indirectly with lipid moieties [65]